Upper airway stimulation for obstructive sleep apnea

• Verfasst von: Gillespie, M. Boyd [VerfasserIn]
• Verfasst von: Maurer, Joachim T. [VerfasserIn]
• Titel: Upper airway stimulation for obstructive sleep apnea
• Titelzusatz: patient-reported outcomes after 48 months of follow-up
• Verf.angabe: M. Boyd Gillespie, MD, MSc, Ryan J. Soose, MD, B. Tucker Woodson, MD, Kingman P. Strohl, MD, Joachim T. Maurer, MD, Nico de Vries, MD, David L. Steward, MD, Jonathan Z. Baskin, MD; M. Safwan Badr, MD; Ho-sheng Lin, MD; Tapan A. Padhya, MD; Sam Mickelson, MD; W. McDowell Anderson, MD; Olivier M. Vanderveken, MD, and Patrick J. Strollo Jr, MD; on behalf of the STAR Trial Investigators
• Jahr: 2017
• Umfang: 7 S.
• Fussnoten: Article first published online: February 14, 2017 ; Gesehen am 27.06.2018 ; This article was presented at the 2016 AAO-HNSF Annual Meeting & OTOEXPO; September 18-21, 2016; San Diego, California
• Titel Quelle: Enthalten in: Head and neck surgery
• Ort Quelle: [Place of publication not identified] : LWW, 2013
• Jahr Quelle: 2017
• Band/Heft Quelle: 156(2017), 4, Seite 765-771
• ISBN Quelle: 978-1-4698-5601-8
• ISBN Quelle: 1-4698-5601-8
• DOI: doi:10.1177/0194599817691491
• Datenträger: Online-Ressource
• Sprache: eng
• K10plus-PPN: 1576888940

Abstract

ObjectiveTo assess patient-based outcomes of participants in a large cohort study?the STAR trial (Stimulation Therapy for Apnea Reduction)?48 months after implantation with an upper airway stimulation system for moderate to severe obstructive sleep apnea.Study DesignA multicenter prospective cohort study.SettingIndustry-supported multicenter academic and clinical setting.SubjectsParticipants (n = 91) at 48 months from a cohort of 126 implanted participants.MethodsA total of 126 participants received an implanted upper airway stimulation system in a prospective phase III trial. Patient-reported outcomes at 48 months, including Epworth Sleepiness Scale (ESS), Functional Outcomes of Sleep Questionnaire (FOSQ), and snoring level, were compared with preimplantation baseline.ResultsA total of 91 subjects completed the 48-month visit. Daytime sleepiness as measured by ESS was significantly reduced (P = .01), and sleep-related quality of life as measured by FOSQ significantly improved (P = .01) when compared with baseline. Soft to no snoring was reported by 85% of bed partners. Two patients required additional surgery without complication for lead malfunction.ConclusionUpper airway stimulation maintained a sustained benefit on patient-reported outcomes (ESS, FOSQ, snoring) at 48 months in select patients with moderate to severe obstructive sleep apnea.